Venus Remedies Limited
₹675-1.51%Feb 27, 2:00 PM IST
VENUSREM•Health Technology•Pharmaceuticals: Major
Current Price
₹675-1.51%
Feb 27, 2:00 PM ISTMarket Cap₹915.04 Cr
Market Cap₹915.04 Cr
Business Overview
Venus Remedies Limited operates through 4 main business divisions including Research & Development (R&D), Manufacturing Operations, Marketing & Sales, Consumer Healthcare (RESET).
Business Hierarchy Structure for Venus Remedies Limited
- Venus Remedies Limited
- Research & Development (R&D)
- Venus Medicine Research Centre (VMRC)
- Therapeutic Areas of Focus
- Antimicrobial Resistance (AMR)
- Oncology
- Skin & Wound Care
- Neurology
- Pain Management
- Herbal Portfolio
- Disinfectants
- Functional Divisions
- Analytical Research
- Formulation & Development
- Pre-Clinical & DMPK (Drug Metabolism and Pharmacokinetics)
- Cell Culture and Microbial Biotechnology
- Clinical Research
- Natural Product Research Lab (NPRL)
- Intellectual Property Rights (IPR)
- Strategic Business Development (SBD)
- Drug Regulatory Affairs
- Pharmacovigilance
- Therapeutic Areas of Focus
- Venus Medicine Research Centre (VMRC)
- Manufacturing Operations
- Panchkula Facility (India)
- Baddi Facility (India)
- Werne Facility (Germany)
- Marketing & Sales
- Domestic Business
- Institutional Business (Government Business & CDMO Projects)
- Davai App (B2B E-commerce Platform)
- International Business
- Global Presence (90+ Nations)
- Market Expansion (France, Romania, Kyrgyzstan, Libya, Zimbabwe, Senegal, Kuwait)
- Domestic Business
- Consumer Healthcare (RESET)
- RESET - Pain Relief
- Candies
- Ultra Potent Gel
- Easy to Rub Emulsion
- Instant Ease Tablets
- Soothing Gel
- Deep Penetrating Spray
- RESET - Wellness
- Liver Health
- Weight Management
- Ashwagandha +Vit D Gummies
- RESET - Vitals
- Vit C Gummies
- B-complex Gummies
- Biotin Gummies
- Multivitamin Gummies
- RESET - Yoga
- Stretch Easy Oil
- RESET - Pain Relief
- Research & Development (R&D)